- Article metrics
- Last updated: Thu, 18 Apr 2024 7:00:35 Z
Efficacy and tolerability of a low-dose, 2-week administration of sunitinib followed by a week rest (2/1 schedule) for metastatic renal cell carcinoma: a single center experience of six cases
Access & Citations
-
- 1159
- Article Accesses
-
- 0
- Web of Science
-
- 7
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.